Navigation Links
ChromaDex Announces Financial Results for Second Quarter 2011
Date:8/11/2011

te or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.Investor Inquiries:Liviakis Financial Communications, Inc.John M. Liviakis, President415-389-4670John@Liviakis.comChromaDex Contact Laura CarneyExecutive Assistant to the CEO, President, and CFO10005 Muirlands Blvd, Suite G, Irvine, CA 92618949-419-0288LauraC@chromadex.comChromaDex Corporation and SubsidiariesCondensed Consolidated Statements of Operations (Unaudited)For the Three Month Periods Ended July 2, 2011 and July 3, 2010July 2, 2011July 3, 2010Sales

$
,937,976$
2,033,861Cost of sales

1,357,0581,258,172Gross profit580,918775,689Operating expenses:Sales and marketing

565,975228,351General and administrative

1,849,733840,538Operating expenses2,415,7081,068,889Operating loss (1,834,790)(293,200)Nonoperating income (expenses):Interest income

430397Interest expense

(8,209)(10,726)Nonoperating loss(7,779)(10,329)Net loss$
(1,842,569)$
(303,529)Basic and Diluted loss per common share

$
(0.03)$
(0.01)Basic and Diluted average common shares outstanding

65,001,97943,623,403See Notes to Condensed Consolidated Financial Statements.Quantitative Reconciliation of the differences between the non-GAAP measure and the associated comparable GAAP measureCondensed Consolidated Statements of Operations (Unaudited, US GAAP) For the Three Month Periods Ended July 2, 2011 and July 3, 2010July 2, 2011July 3, 2010Sales

$   1,937,976$   2,033,861Cost of sales

1,357,0581,258,172Gross profit580,918775,689Operating expenses:Sales and marketing

565,975228,351General and administrative

1,849,733840,538Operating expenses

2,415,7081,068,889Operating loss (1,834,790)(293,200)Nonoperating income (expenses):Intere
'/>"/>

SOURCE ChromaDex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ChromaDex Partners With Kappa Bioscience to Provide Quality Control Methods, Tools and Services for Vitamin K2
2. ChromaDex and Bruker Optics Sign Agreement to Expedite Dietary Supplement Testing for Compliance With FDA Good Manufacturing Practice Requirements
3. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
4. Life Extension® Launches New Product Containing ChromaDexs pTeroPure® Pterostilbene
5. ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... and RALEIGH, N.C. , Dec. ... Endo International plc (NASDAQ: ENDP ) (TSX: ... BDSI ) announced today that they have submitted a ... to the U.S. Food and Drug Administration (FDA).  Buprenorphine ... of pain severe enough to require daily, around-the-clock, long-term ...
(Date:12/22/2014)... 2014 NxStage Medical, Inc. (NASDAQ: ... products, announced today that the U.S. Food and ... to perform hemodialysis overnight while the patient is ... NxStage,s® System One is the first and only ... indication. Home nocturnal hemodialysis is ...
(Date:12/22/2014)... MEMPHIS, Tenn. , Dec. 22, 2014   ... only automated, no-touch UV disinfection robot, announced today that ... GSA Schedule contract through November 2019.   ... to rapidly engage all levels of government purchasers, including ... facilities, as well as Homeland Security contacts purchasing solutions ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
...  Qforma, a healthcare data analytics and predictive modeling ... Mark Feeney has been appointed Vice ... than 20 years of experience in the life ... force effectiveness strategies and territory optimization initiatives.  ...
...  Today Gradalis, Inc., announced that FANG™, the company,s ... lasting immune response, resulting in statistically-significant prolonged survival ... 1 study, published today in the Nature Publishing ... treatment with FANG significantly increased survival in patients ...
Cached Medicine Technology:Study Published in Molecular Therapy Shows that Immune Response to FANG™ Personalized Cancer Therapeutic Correlates with Prolonged Survival in Patients with Advanced Stage Cancer 2Study Published in Molecular Therapy Shows that Immune Response to FANG™ Personalized Cancer Therapeutic Correlates with Prolonged Survival in Patients with Advanced Stage Cancer 3
(Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
(Date:12/26/2014)... December 26, 2014 “Many people become ... personal injury claim issues and phone calls with insurance ... an article featuring their free eBook on pedestrian ... eBook on pedestrian and bicycle auto accident claims assures ... fully capable of professionally handling their case while they ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 Parker ... for the best in heating, cooling and plumbing ... 24 hour emergency services in 2014 with regard ... know that Arizona is known for its incredibly ... that understands the intricacies and details of a ...
(Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
(Date:12/25/2014)... 2014 Recently, iFitDress.com, the popular online supplier ... announced its new selection of black one-shoulder cocktail dresses ... now; they are available at discounted prices, up to 70% ... will last for three weeks only. You know, we have ... are interested in our new items can visit our website ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... have become nearly twice as prevalent in high schools in ... of middle school students admit that drugs are used, kept ... schools where drugs are widely available are three times more ... use alcohol than their peers who attend drug-free schools., ...
... developed two centuries ago by a German physician, is ... though conventional medicine still views it with scepticism. //, ... homeopathy on the idea of "like cures like"., ... bark was prescribed to combat malaria but also caused ...
... people who are more exposed to graffiti on the walls ... more likely to become obese than their counterparts living with ... published in the latest edition of BMJ., ,Obesity levels ... place of residence may be associated with levels of obesity ...
... India, hence experts say they are concerned that the unchecked ... on quality and ethical standards while conducting drug trials. // ... Research (ISCR), Dr. Shoibal Mukherjee has recently said that a ... is currently on and says that India has a special ...
... up its third state of the art drug ... by President A.P.J. Abdul Kalam on 16th August ... new drug // discovery research and the development ... technologies, infectious diseases, metabolism and pharmacokinetics., ,Dr ...
... for treatment for heart attacks, may be more at ... flow, said a research // findings in the latest ... flow to an organ or tissue) with either fibrinolytic ... intervention (PCI; procedures such as angioplasty in which a ...
Cached Medicine News:Health News:Popularity Of Homeopathy On The Increase 2Health News:Popularity Of Homeopathy On The Increase 3Health News:Exposure To Greenery And Graffiti May Affect Obesity 2Health News:Heart Attack Patients Reaching Hospital During Off-Hours Have Increased Risk Of Death 2
Near and far chart set provides letter and number matrix for testing and accommodative vision training. Set includes 1-8 1/2 X 11 chart on white card with black print and 2-3X5 laminated white card w...
... The Eger NP card provides references to many ... to small legal contract size. This provides the ... Eger card is printed with black ink on ... from Snellen 20/1000 to 20/20. Other notations include ...
... card was designed by James Lebensohn, MD ... point exercises including words, numbers and OX ... 20/100, 20/65, 20/50, 20/40, 20/30, 20/25, and ... English and metric, Jaeger, point size and ...
Standard reading test. 'It was the month of May'...
Medicine Products: